Cite
Trends in aetiology‐based hospitalisation for cirrhosis before and during the COVID‐19 pandemic in the United States.
MLA
Kim, Donghee, et al. “Trends in Aetiology‐based Hospitalisation for Cirrhosis before and during the COVID‐19 Pandemic in the United States.” Alimentary Pharmacology & Therapeutics, vol. 58, no. 2, July 2023, pp. 218–28. EBSCOhost, https://doi.org/10.1111/apt.17547.
APA
Kim, D., Perumpail, B. J., Wijarnpreecha, K., Manikat, R., Cholankeril, G., & Ahmed, A. (2023). Trends in aetiology‐based hospitalisation for cirrhosis before and during the COVID‐19 pandemic in the United States. Alimentary Pharmacology & Therapeutics, 58(2), 218–228. https://doi.org/10.1111/apt.17547
Chicago
Kim, Donghee, Brandon J. Perumpail, Karn Wijarnpreecha, Richie Manikat, George Cholankeril, and Aijaz Ahmed. 2023. “Trends in Aetiology‐based Hospitalisation for Cirrhosis before and during the COVID‐19 Pandemic in the United States.” Alimentary Pharmacology & Therapeutics 58 (2): 218–28. doi:10.1111/apt.17547.